Company profile GRTX
There is not enough data for Galera Therapeutics -stock to provide analysis
There is not enough data for Galera Therapeutics -stock to provide correlation calculation
There is not enough data for Galera Therapeutics -stock to provide analysis
There is not enough data for Galera Therapeutics clinical trials to provide analysis
There is not enough data for Galera Therapeutics clinical trials to provide correlation calculation
There is not enough data for Galera Therapeutics clinical trials to provide analysis
There is not enough data for avasopasem manganese to provide analysis
There is not enough data for avasopasem manganese to provide correlation calculation
There is not enough data for avasopasem manganese to provide analysis
There is not enough data for radiotherapy-induced oral mucositis treatment to provide analysis
There is not enough data for radiotherapy-induced oral mucositis treatment to provide correlation calculation
There is not enough data for radiotherapy-induced oral mucositis treatment to provide analysis
There is not enough data for radiotherapy-induced esophagitis treatment to provide analysis
There is not enough data for radiotherapy-induced esophagitis treatment to provide correlation calculation
There is not enough data for radiotherapy-induced esophagitis treatment to provide analysis
There is not enough data for GC4711 clinical trial to provide analysis
There is not enough data for GC4711 clinical trial to provide correlation calculation
There is not enough data for GC4711 clinical trial to provide analysis
There is not enough data for dismutase mimetic to provide analysis
There is not enough data for dismutase mimetic to provide correlation calculation
There is not enough data for dismutase mimetic to provide analysis
After 38 days of this quarter the interest is at 64.0. Based on that we can calculate that during remaining 53 days it will total up to 153.0. radiotherapy in cancer expected interest is significantly lower compared to previous quarter (-58.5%) and same quarter last year (-62.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 172 | 221 28.5% QoQ | 202 -8.6% QoQ | 314 55.4% QoQ |
| 2020 | 254 47.7% YoY -19.1% QoQ | 202 -8.6% YoY -20.5% QoQ | 223 10.4% YoY 10.4% QoQ | 129 -58.9% YoY -42.2% QoQ |
| 2021 | 299 17.7% YoY 131.8% QoQ | 153 -24.3% YoY -48.8% QoQ | 127 -43.0% YoY -17.0% QoQ | 243 88.4% YoY 91.3% QoQ |
| 2022 | 408 36.5% YoY 67.9% QoQ | 282 84.3% YoY -30.9% QoQ | 271 113.4% YoY -3.9% QoQ | 351 44.4% YoY 29.5% QoQ |
| 2023 | 409 0.2% YoY 16.5% QoQ | 369 30.9% YoY -9.8% QoQ | 375 38.4% YoY 1.6% QoQ | 369 5.1% YoY -1.6% QoQ |
| 2024 | 64 -84.4% YoY -82.7% QoQ | - | - | - |
The average 5 years interest of radiotherapy in cancer was 20.91 per week. The last year interest of radiotherapy in cancer compared to the last 5 years has changed by 36.78%. The interest for radiotherapy in cancer is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 49.58%.
After 34 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 58 days it will total up to 38.0. biopharmaceutical company expected interest is significantly lower compared to previous quarter (-57.8%) and same quarter last year (-72.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 127 |
| 2019 | 118 -7.1% QoQ | 78 -33.9% QoQ | 153 96.2% QoQ | 205 61.4% YoY 34.0% QoQ |
| 2020 | 101 -14.4% YoY -50.7% QoQ | 226 189.7% YoY 123.8% QoQ | 71 -53.6% YoY -68.6% QoQ | 38 -81.5% YoY -46.5% QoQ |
| 2021 | 84 -16.8% YoY 121.1% QoQ | 188 -16.8% YoY 123.8% QoQ | 58 -18.3% YoY -69.1% QoQ | 87 128.9% YoY 50.0% QoQ |
| 2022 | 170 102.4% YoY 95.4% QoQ | 75 -60.1% YoY -55.9% QoQ | 134 131.0% YoY 78.7% QoQ | 138 58.6% YoY 3.0% QoQ |
| 2023 | 118 -30.6% YoY -14.5% QoQ | 54 -28.0% YoY -54.2% QoQ | 90 -32.8% YoY 66.7% QoQ | 14 -89.9% YoY -84.4% QoQ |
The average 5 years interest of biopharmaceutical company was 8.92 per week. The last year interest of biopharmaceutical company compared to the last 5 years has changed by -26.91%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -43.79%.
After 39 days of this quarter the interest is at 349.0. Based on that we can calculate that during remaining 52 days it will total up to 814.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 324 | 608 87.7% QoQ | 438 -28.0% QoQ | 515 17.6% QoQ |
| 2020 | 627 93.5% YoY 21.7% QoQ | 640 5.3% YoY 2.1% QoQ | 546 24.7% YoY -14.7% QoQ | 506 -1.7% YoY -7.3% QoQ |
| 2021 | 670 6.9% YoY 32.4% QoQ | 469 -26.7% YoY -30.0% QoQ | 438 -19.8% YoY -6.6% QoQ | 438 -13.4% YoY 0.0% QoQ |
| 2022 | 804 20.0% YoY 83.6% QoQ | 638 36.0% YoY -20.6% QoQ | 571 30.4% YoY -10.5% QoQ | 710 62.1% YoY 24.3% QoQ |
| 2023 | 788 -2.0% YoY 11.0% QoQ | 622 -2.5% YoY -21.1% QoQ | 604 5.8% YoY -2.9% QoQ | 855 20.4% YoY 41.6% QoQ |
| 2024 | 349 -55.7% YoY -59.2% QoQ | - | - | - |
The average 5 years interest of healthcare sector was 46.59 per week. The last year interest of healthcare sector compared to the last 5 years has changed by 18.22%. The interest for healthcare sector is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 37.77%.